Revenue (Annual) Chart

View Revenue (Annual) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2025 66.59M
June 30, 2024 53.84M
June 30, 2023 46.09M
June 30, 2022 42.04M
June 30, 2021 38.03M
June 30, 2020 34.83M
June 30, 2019 27.17M
June 30, 2018 22.46M
June 30, 2017 21.94M
June 30, 2016 19.19M
June 30, 2015 13.38M
June 30, 2014 10.81M
June 30, 2013 12.25M
June 30, 2012 17.26M
Date Value
June 30, 2011 27.11M
June 30, 2010 23.21M
June 30, 2009 21.12M
June 30, 2008 25.13M
June 30, 2007 21.56M
June 30, 2006 17.06M
June 30, 2005 13.83M
June 30, 2004 14.20M
June 30, 2003 11.99M
June 30, 2002 10.53M
June 30, 2001 14.84M
June 30, 2000 26.67M
June 30, 1999 18.34M
June 30, 1998 22.65M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Abbott Laboratories 44.33B
AngioDynamics, Inc. 320.17M
Alphatec Holdings, Inc. 764.16M
AtriCure, Inc. 534.53M
Baxter International, Inc. 11.24B